Image
user avatar
insitro
@insitro
Making medicines differently to bring better drugs faster to the patients who benefit most with ML and data at scale.
South San Francisco, CA
Joined May 2018
Posts
  • user avatar
    We're thrilled to announce our $400M Series C financing, which will greatly enable us to continue advancing our vision to reshape the discovery and development of transformative medicines by leveraging #machinelearning and biology and chemistry at scale. bwnews.pr/3eL7G7v
    Image
    00:00
  • user avatar
    We're excited to announce the open sourcing of redun, an expressive, efficient, and easy-to-use workflow framework designed to deal with complex, rapidly evolving scientific workflows spanning multiple data types. Read more here: insitro.medium.com/8b06b707a14b
    Image
    GIF
  • user avatar
    We are excited to announce the closing of our $143 million Series B financing, supporting expansion of our #machinelearning and data generation capabilities to enable advancement of therapies toward the clinic. #ML4Medicines Read more here: bwnews.pr/2yxsoor
    Image
  • user avatar
    We're pleased to share a look into part of our biology discovery platform, CellPaint-POSH, an ML-enabled high-content pooled optical screening system. Our research shows pooled genetic screening w/ cellular imaging can enhance gene function understanding. biorxiv.org/content/10.110…
    Image
  • user avatar
    Congratulations to our Founder & CEO @DaphneKoller for receiving the Allen Newell Award for seminal contributions to machine learning & probabilistic models, the application of these techniques to biology & human health, & for contributions to democratizing education
    ACM-AAAI Allen Newell Award recipient @DaphneKoller has been instrumental in using #MachineLearning as a tool to advance biology and medicine. As a co-founder of @coursera, she has also made great contributions to democratizing education: bit.ly/3cNGS2p
    Image
  • user avatar
    (1/3) insitro is excited to share our paper “EmbedGEM: A Framework to Evaluate the Utility of Embeddings for Genetic Discovery,” focusing on assessing the use of ML-derived embeddings for genetic discovery using heritability & relevance to specific diseases.
    Image
    00:00
  • user avatar
    We're thrilled to announce our collaboration with @bmsnews that focuses on the discovery and development of novel therapies for the treatment of #ALS. Read more: bwnews.pr/3e29OoI
    Image
    00:00
  • user avatar
    insitro welcomes @SerafimBatz as Chief Data Officer. His expertise in ML and computational genomics will accelerate our progress towards our mission of leading the way to better medicines through predictive models that integrate ML and biology at scale.
  • user avatar
    Tomorrow, our CEO & founder @DaphneKoller takes the virtual @TechCrunch Disrupt stage as she talks about our mission of transforming pharma R&D through #machinelearning and data at scale. Watch the livestream here: tcrn.ch/2FBrCKv #TCDisrupt
    Image
  • user avatar
    We’re very proud to share that insitro CEO & Founder @DaphneKoller has been elected to the National Academy of Sciences in recognition of her pioneering contributions to Machine Learning. Congratulations to Daphne and her distinguished peers for this prestigious recognition! #ML
    We are thrilled to announce the election of 120 members and 23 international members to the National Academy of Sciences in recognition of their distinguished and continued achievements in original research. bit.ly/3HyRx2u Congratulations to our new #NASmembers! #NAS160
    Image
    00:00
  • user avatar
    If you missed our CEO and founder @DaphneKoller's talk at @TechCrunch Disrupt yesterday, hear why she says digital biology is the next big technological revolution and how insitro is using it to shift the trajectory of drug discovery. #TCDisrupt
  • user avatar
    We're excited to announce our acquisition of Haystack Sciences, leveraging their leading-edge DEL technology, and advancing our aim to become a fully integrated drug discovery and development company. Read the release: businesswire.com/news/home/2020…
    Image
    00:00
  • user avatar
    Our CEO @DaphneKoller spoke with @RuthReader to discuss what's next following our Series B and how #machinelearning could be the key to cracking the code to drug development. Read below! #ML4Medicines
    Combining AI and biology could solve drug discovery’s biggest problems f-st.co/rgHMKO3
  • user avatar
    We're proud to share that our CEO and founder @DaphneKoller is the recipient of this year's #IEECS Women of ENIAC Computer Pioneer Award. Congratulations, Daphne! 🎉
    Congrats to Daphne Koller and her achievement of the 2022 #IEEECS Women of ENIAC Computer Pioneer Award for “contributions to representation, inference, and learning in probabilistic models with applications to computational biology and human health.” bit.ly/3BMRfB1
    Image